FACTS AT A GLANCE
Edition: 16; Released: June 2021
Executive Pool: 2751
Companies: 46 – Players covered include AnkeBio Co. Ltd; Eli Lilly and Company; EMD Serono Inc.; Ferring Pharmaceuticals; Genentech, Inc (Roche); GeneScience Pharmaceuticals Co. Ltd; Ipsen S.A.; LG Life Sciences; Merck KGaA; Novo Nordisk A/S; Pfizer, Inc; Sandoz International GmbH (Novartis AG); Strongbridge Biopharma; Teva Pharmaceutical Industries, Ltd and Others.
Coverage: All major geographies and key segments
Segments: Route of Administration (Subcutaneous, Intramuscular, Intravenous, Oral); Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy); Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS), Other Applications)
Geographies: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Latin America; Middle East; Africa.
Complimentary Project Preview – This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform…
